Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)
CNY 14.38
(0.0%)
CNY 14.38
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -81.67 Million CNY | -185.82% |
| 2022 | 95.16 Million CNY | -36.89% |
| 2021 | 150.79 Million CNY | -28.78% |
| 2020 | 211.74 Million CNY | 942.87% |
| 2019 | -25.12 Million CNY | 39.26% |
| 2018 | -41.35 Million CNY | 12.62% |
| 2017 | -47.32 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -24.5 Million CNY | 17.0% |
| 2024 Q1 | -29.52 Million CNY | 54.56% |
| 2024 Q3 | -14.6 Million CNY | 40.41% |
| 2023 Q3 | -57.44 Million CNY | -11301.53% |
| 2023 Q1 | 41.23 Million CNY | 407.24% |
| 2023 FY | -81.67 Million CNY | -185.82% |
| 2023 Q2 | -503.84 Thousand CNY | -101.22% |
| 2023 Q4 | -64.96 Million CNY | -13.08% |
| 2022 Q3 | 74.35 Million CNY | 427.03% |
| 2022 Q2 | -22.73 Million CNY | -159.6% |
| 2022 Q1 | -8.75 Million CNY | 76.05% |
| 2022 FY | 95.16 Million CNY | -36.89% |
| 2022 Q4 | -13.42 Million CNY | -118.05% |
| 2021 Q4 | -36.56 Million CNY | -124.75% |
| 2021 FY | 150.79 Million CNY | -28.78% |
| 2021 Q3 | 147.72 Million CNY | 803.82% |
| 2021 Q1 | -6.2 Million CNY | -104.38% |
| 2021 Q2 | -20.98 Million CNY | -238.37% |
| 2020 FY | 211.74 Million CNY | 942.87% |
| 2020 Q2 | -8.41 Million CNY | -264.16% |
| 2020 Q1 | 5.12 Million CNY | 0.0% |
| 2020 Q3 | 73.56 Million CNY | 974.62% |
| 2020 Q4 | 141.46 Million CNY | 92.29% |
| 2019 FY | -25.12 Million CNY | 39.26% |
| 2018 FY | -41.35 Million CNY | 12.62% |
| 2017 FY | -47.32 Million CNY | 0.0% |